nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—Barrett's esophagus—esophageal cancer	0.486	1	CtDrD
Omeprazole—ATP4A—esophageal cancer	0.176	0.631	CbGaD
Omeprazole—CYP1B1—esophageal cancer	0.0801	0.287	CbGaD
Omeprazole—ABCC3—Cisplatin—esophageal cancer	0.0364	0.285	CbGbCtD
Omeprazole—ABCC3—Methotrexate—esophageal cancer	0.0236	0.185	CbGbCtD
Omeprazole—ABCB1—esophageal cancer	0.023	0.0822	CbGaD
Omeprazole—ABCG2—Carboplatin—esophageal cancer	0.0175	0.137	CbGbCtD
Omeprazole—ABCG2—Cisplatin—esophageal cancer	0.0149	0.117	CbGbCtD
Omeprazole—CYP2C9—Capecitabine—esophageal cancer	0.011	0.0864	CbGbCtD
Omeprazole—ABCG2—Methotrexate—esophageal cancer	0.0097	0.076	CbGbCtD
Omeprazole—ATP4A—gastric juice—esophageal cancer	0.0095	0.414	CbGeAlD
Omeprazole—CYP2C9—Cisplatin—esophageal cancer	0.00555	0.0435	CbGbCtD
Omeprazole—ABCB1—Cisplatin—esophageal cancer	0.00539	0.0422	CbGbCtD
Omeprazole—ATP4A—larynx—esophageal cancer	0.00422	0.184	CbGeAlD
Omeprazole—ABCB1—Methotrexate—esophageal cancer	0.0035	0.0274	CbGbCtD
Omeprazole—ATP4B—digestive system—esophageal cancer	0.00133	0.058	CbGeAlD
Omeprazole—ATP4A—neck—esophageal cancer	0.00112	0.0488	CbGeAlD
Omeprazole—Esomeprazole—ATP4A—esophageal cancer	0.00081	0.295	CrCbGaD
Omeprazole—ATP4A—epithelium—esophageal cancer	0.000762	0.0332	CbGeAlD
Omeprazole—CYP2C18—bronchus—esophageal cancer	0.000617	0.0269	CbGeAlD
Omeprazole—Pantoprazole—ATP4A—esophageal cancer	0.000586	0.213	CrCbGaD
Omeprazole—Rabeprazole—ATP4A—esophageal cancer	0.000586	0.213	CrCbGaD
Omeprazole—ATP4A—digestive system—esophageal cancer	0.00058	0.0253	CbGeAlD
Omeprazole—CYP2C18—digestive system—esophageal cancer	0.000476	0.0208	CbGeAlD
Omeprazole—Lansoprazole—ATP4A—esophageal cancer	0.000437	0.159	CrCbGaD
Omeprazole—ABCC3—digestive system—esophageal cancer	0.000295	0.0129	CbGeAlD
Omeprazole—CYP1B1—smooth muscle tissue—esophageal cancer	0.000292	0.0127	CbGeAlD
Omeprazole—ABCC3—lung—esophageal cancer	0.000246	0.0107	CbGeAlD
Omeprazole—CYP1B1—digestive system—esophageal cancer	0.000231	0.0101	CbGeAlD
Omeprazole—CYP11A1—lymph node—esophageal cancer	0.000217	0.00946	CbGeAlD
Omeprazole—CYP1A1—epithelium—esophageal cancer	0.000214	0.00934	CbGeAlD
Omeprazole—CYP1A1—bronchus—esophageal cancer	0.000211	0.0092	CbGeAlD
Omeprazole—CYP2C19—digestive system—esophageal cancer	0.000203	0.00882	CbGeAlD
Omeprazole—Lansoprazole—CYP1B1—esophageal cancer	0.000198	0.0721	CrCbGaD
Omeprazole—CYP1B1—lung—esophageal cancer	0.000193	0.0084	CbGeAlD
Omeprazole—CYP1A1—trachea—esophageal cancer	0.00019	0.00826	CbGeAlD
Omeprazole—ABCC3—lymph node—esophageal cancer	0.000168	0.00734	CbGeAlD
Omeprazole—CYP1A2—digestive system—esophageal cancer	0.000165	0.00721	CbGeAlD
Omeprazole—CYP1A1—digestive system—esophageal cancer	0.000163	0.00711	CbGeAlD
Omeprazole—CYP2C9—digestive system—esophageal cancer	0.000157	0.00684	CbGeAlD
Omeprazole—ABCG2—lung—esophageal cancer	0.000144	0.00625	CbGeAlD
Omeprazole—CYP1A2—lung—esophageal cancer	0.000138	0.00602	CbGeAlD
Omeprazole—CYP1A1—lung—esophageal cancer	0.000136	0.00594	CbGeAlD
Omeprazole—CYP1B1—lymph node—esophageal cancer	0.000132	0.00574	CbGeAlD
Omeprazole—CYP3A4—digestive system—esophageal cancer	0.00012	0.00522	CbGeAlD
Omeprazole—CYP2D6—digestive system—esophageal cancer	0.000118	0.00513	CbGeAlD
Omeprazole—ABCB1—epithelium—esophageal cancer	0.000111	0.00485	CbGeAlD
Omeprazole—ABCB1—trachea—esophageal cancer	9.85e-05	0.00429	CbGeAlD
Omeprazole—ABCG2—lymph node—esophageal cancer	9.82e-05	0.00428	CbGeAlD
Omeprazole—Neoplasm—Methotrexate—esophageal cancer	9.33e-05	0.00257	CcSEcCtD
Omeprazole—Urine output increased—Methotrexate—esophageal cancer	9.33e-05	0.00257	CcSEcCtD
Omeprazole—Bladder pain—Methotrexate—esophageal cancer	9.33e-05	0.00257	CcSEcCtD
Omeprazole—Urinary tract disorder—Cisplatin—esophageal cancer	9.33e-05	0.00257	CcSEcCtD
Omeprazole—CYP1A1—lymph node—esophageal cancer	9.32e-05	0.00406	CbGeAlD
Omeprazole—Connective tissue disorder—Cisplatin—esophageal cancer	9.28e-05	0.00256	CcSEcCtD
Omeprazole—Urethral disorder—Cisplatin—esophageal cancer	9.26e-05	0.00255	CcSEcCtD
Omeprazole—Gynaecomastia—Methotrexate—esophageal cancer	9.24e-05	0.00254	CcSEcCtD
Omeprazole—Dry skin—Capecitabine—esophageal cancer	9.23e-05	0.00254	CcSEcCtD
Omeprazole—Abdominal pain upper—Capecitabine—esophageal cancer	9.19e-05	0.00253	CcSEcCtD
Omeprazole—Hypokalaemia—Capecitabine—esophageal cancer	9.16e-05	0.00252	CcSEcCtD
Omeprazole—Visual impairment—Cisplatin—esophageal cancer	9.1e-05	0.00251	CcSEcCtD
Omeprazole—Breast disorder—Capecitabine—esophageal cancer	9.1e-05	0.00251	CcSEcCtD
Omeprazole—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	9.06e-05	0.0025	CcSEcCtD
Omeprazole—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	9.06e-05	0.0025	CcSEcCtD
Omeprazole—Gastritis—Capecitabine—esophageal cancer	8.91e-05	0.00245	CcSEcCtD
Omeprazole—Muscular weakness—Capecitabine—esophageal cancer	8.88e-05	0.00245	CcSEcCtD
Omeprazole—Alanine aminotransferase increased—Capecitabine—esophageal cancer	8.88e-05	0.00245	CcSEcCtD
Omeprazole—Eye disorder—Cisplatin—esophageal cancer	8.83e-05	0.00243	CcSEcCtD
Omeprazole—Tinnitus—Cisplatin—esophageal cancer	8.81e-05	0.00243	CcSEcCtD
Omeprazole—Lymphadenopathy—Methotrexate—esophageal cancer	8.78e-05	0.00242	CcSEcCtD
Omeprazole—Flushing—Cisplatin—esophageal cancer	8.77e-05	0.00241	CcSEcCtD
Omeprazole—Abdominal distension—Capecitabine—esophageal cancer	8.76e-05	0.00241	CcSEcCtD
Omeprazole—Influenza—Capecitabine—esophageal cancer	8.7e-05	0.0024	CcSEcCtD
Omeprazole—Asthma—Capecitabine—esophageal cancer	8.7e-05	0.0024	CcSEcCtD
Omeprazole—Dysphagia—Capecitabine—esophageal cancer	8.7e-05	0.0024	CcSEcCtD
Omeprazole—Bronchospasm—Capecitabine—esophageal cancer	8.56e-05	0.00236	CcSEcCtD
Omeprazole—Polyuria—Methotrexate—esophageal cancer	8.53e-05	0.00235	CcSEcCtD
Omeprazole—Photosensitivity—Methotrexate—esophageal cancer	8.53e-05	0.00235	CcSEcCtD
Omeprazole—Immune system disorder—Cisplatin—esophageal cancer	8.53e-05	0.00235	CcSEcCtD
Omeprazole—Mediastinal disorder—Cisplatin—esophageal cancer	8.51e-05	0.00234	CcSEcCtD
Omeprazole—ABCB1—digestive system—esophageal cancer	8.47e-05	0.00369	CbGeAlD
Omeprazole—Sweating increased—Capecitabine—esophageal cancer	8.47e-05	0.00233	CcSEcCtD
Omeprazole—Angina pectoris—Capecitabine—esophageal cancer	8.47e-05	0.00233	CcSEcCtD
Omeprazole—Alopecia—Cisplatin—esophageal cancer	8.35e-05	0.0023	CcSEcCtD
Omeprazole—Hepatic failure—Methotrexate—esophageal cancer	8.34e-05	0.0023	CcSEcCtD
Omeprazole—Pancytopenia—Capecitabine—esophageal cancer	8.26e-05	0.00228	CcSEcCtD
Omeprazole—Malnutrition—Cisplatin—esophageal cancer	8.22e-05	0.00226	CcSEcCtD
Omeprazole—Dysuria—Capecitabine—esophageal cancer	8.13e-05	0.00224	CcSEcCtD
Omeprazole—Neutropenia—Capecitabine—esophageal cancer	8.13e-05	0.00224	CcSEcCtD
Omeprazole—Flatulence—Cisplatin—esophageal cancer	8.1e-05	0.00223	CcSEcCtD
Omeprazole—Upper respiratory tract infection—Capecitabine—esophageal cancer	8.09e-05	0.00223	CcSEcCtD
Omeprazole—Photosensitivity reaction—Capecitabine—esophageal cancer	7.94e-05	0.00219	CcSEcCtD
Omeprazole—Weight increased—Capecitabine—esophageal cancer	7.92e-05	0.00218	CcSEcCtD
Omeprazole—Visual disturbance—Methotrexate—esophageal cancer	7.91e-05	0.00218	CcSEcCtD
Omeprazole—Muscle spasms—Cisplatin—esophageal cancer	7.91e-05	0.00218	CcSEcCtD
Omeprazole—Weight decreased—Capecitabine—esophageal cancer	7.87e-05	0.00217	CcSEcCtD
Omeprazole—Infestation NOS—Capecitabine—esophageal cancer	7.76e-05	0.00214	CcSEcCtD
Omeprazole—Infestation—Capecitabine—esophageal cancer	7.76e-05	0.00214	CcSEcCtD
Omeprazole—Vision blurred—Cisplatin—esophageal cancer	7.75e-05	0.00213	CcSEcCtD
Omeprazole—Depression—Capecitabine—esophageal cancer	7.73e-05	0.00213	CcSEcCtD
Omeprazole—Tremor—Cisplatin—esophageal cancer	7.7e-05	0.00212	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	7.69e-05	0.00212	CcSEcCtD
Omeprazole—Pantoprazole—ABCB1—esophageal cancer	7.63e-05	0.0278	CrCbGaD
Omeprazole—Ill-defined disorder—Cisplatin—esophageal cancer	7.63e-05	0.0021	CcSEcCtD
Omeprazole—Renal failure—Capecitabine—esophageal cancer	7.62e-05	0.0021	CcSEcCtD
Omeprazole—Anaemia—Cisplatin—esophageal cancer	7.6e-05	0.00209	CcSEcCtD
Omeprazole—Stomatitis—Capecitabine—esophageal cancer	7.56e-05	0.00208	CcSEcCtD
Omeprazole—Jaundice—Capecitabine—esophageal cancer	7.56e-05	0.00208	CcSEcCtD
Omeprazole—Urinary tract infection—Capecitabine—esophageal cancer	7.54e-05	0.00208	CcSEcCtD
Omeprazole—Conjunctivitis—Capecitabine—esophageal cancer	7.54e-05	0.00208	CcSEcCtD
Omeprazole—Osteoarthritis—Methotrexate—esophageal cancer	7.49e-05	0.00206	CcSEcCtD
Omeprazole—Malaise—Cisplatin—esophageal cancer	7.42e-05	0.00204	CcSEcCtD
Omeprazole—Haematuria—Capecitabine—esophageal cancer	7.4e-05	0.00204	CcSEcCtD
Omeprazole—Leukopenia—Cisplatin—esophageal cancer	7.36e-05	0.00203	CcSEcCtD
Omeprazole—Hepatobiliary disease—Capecitabine—esophageal cancer	7.34e-05	0.00202	CcSEcCtD
Omeprazole—Epistaxis—Capecitabine—esophageal cancer	7.32e-05	0.00202	CcSEcCtD
Omeprazole—Agranulocytosis—Capecitabine—esophageal cancer	7.24e-05	0.00199	CcSEcCtD
Omeprazole—Irritability—Methotrexate—esophageal cancer	7.15e-05	0.00197	CcSEcCtD
Omeprazole—Bradycardia—Capecitabine—esophageal cancer	7.09e-05	0.00195	CcSEcCtD
Omeprazole—ABCB1—lung—esophageal cancer	7.08e-05	0.00308	CbGeAlD
Omeprazole—Myalgia—Cisplatin—esophageal cancer	7e-05	0.00193	CcSEcCtD
Omeprazole—Rhinitis—Capecitabine—esophageal cancer	6.98e-05	0.00192	CcSEcCtD
Omeprazole—Anxiety—Cisplatin—esophageal cancer	6.98e-05	0.00192	CcSEcCtD
Omeprazole—Hepatitis—Capecitabine—esophageal cancer	6.96e-05	0.00192	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	6.95e-05	0.00192	CcSEcCtD
Omeprazole—Hypoaesthesia—Capecitabine—esophageal cancer	6.93e-05	0.00191	CcSEcCtD
Omeprazole—Discomfort—Cisplatin—esophageal cancer	6.92e-05	0.00191	CcSEcCtD
Omeprazole—Pharyngitis—Capecitabine—esophageal cancer	6.91e-05	0.0019	CcSEcCtD
Omeprazole—Urinary tract disorder—Capecitabine—esophageal cancer	6.88e-05	0.00189	CcSEcCtD
Omeprazole—Oedema peripheral—Capecitabine—esophageal cancer	6.86e-05	0.00189	CcSEcCtD
Omeprazole—Connective tissue disorder—Capecitabine—esophageal cancer	6.84e-05	0.00188	CcSEcCtD
Omeprazole—Urethral disorder—Capecitabine—esophageal cancer	6.83e-05	0.00188	CcSEcCtD
Omeprazole—Breast disorder—Methotrexate—esophageal cancer	6.77e-05	0.00187	CcSEcCtD
Omeprazole—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	6.75e-05	0.00186	CcSEcCtD
Omeprazole—Anaphylactic shock—Cisplatin—esophageal cancer	6.71e-05	0.00185	CcSEcCtD
Omeprazole—Visual impairment—Capecitabine—esophageal cancer	6.71e-05	0.00185	CcSEcCtD
Omeprazole—Infection—Cisplatin—esophageal cancer	6.67e-05	0.00184	CcSEcCtD
Omeprazole—Erythema multiforme—Capecitabine—esophageal cancer	6.58e-05	0.00181	CcSEcCtD
Omeprazole—Nervous system disorder—Cisplatin—esophageal cancer	6.58e-05	0.00181	CcSEcCtD
Omeprazole—Thrombocytopenia—Cisplatin—esophageal cancer	6.57e-05	0.00181	CcSEcCtD
Omeprazole—Tachycardia—Cisplatin—esophageal cancer	6.55e-05	0.0018	CcSEcCtD
Omeprazole—Skin disorder—Cisplatin—esophageal cancer	6.52e-05	0.0018	CcSEcCtD
Omeprazole—Eye disorder—Capecitabine—esophageal cancer	6.51e-05	0.00179	CcSEcCtD
Omeprazole—Tinnitus—Capecitabine—esophageal cancer	6.49e-05	0.00179	CcSEcCtD
Omeprazole—Hyperhidrosis—Cisplatin—esophageal cancer	6.49e-05	0.00179	CcSEcCtD
Omeprazole—Asthma—Methotrexate—esophageal cancer	6.48e-05	0.00178	CcSEcCtD
Omeprazole—Flushing—Capecitabine—esophageal cancer	6.46e-05	0.00178	CcSEcCtD
Omeprazole—Anorexia—Cisplatin—esophageal cancer	6.4e-05	0.00176	CcSEcCtD
Omeprazole—Pancreatitis—Methotrexate—esophageal cancer	6.35e-05	0.00175	CcSEcCtD
Omeprazole—Immune system disorder—Capecitabine—esophageal cancer	6.29e-05	0.00173	CcSEcCtD
Omeprazole—Mediastinal disorder—Capecitabine—esophageal cancer	6.28e-05	0.00173	CcSEcCtD
Omeprazole—Chills—Capecitabine—esophageal cancer	6.25e-05	0.00172	CcSEcCtD
Omeprazole—Alopecia—Capecitabine—esophageal cancer	6.15e-05	0.00169	CcSEcCtD
Omeprazole—Pancytopenia—Methotrexate—esophageal cancer	6.15e-05	0.00169	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Cisplatin—esophageal cancer	6.11e-05	0.00168	CcSEcCtD
Omeprazole—Mental disorder—Capecitabine—esophageal cancer	6.1e-05	0.00168	CcSEcCtD
Omeprazole—Malnutrition—Capecitabine—esophageal cancer	6.06e-05	0.00167	CcSEcCtD
Omeprazole—Dysuria—Methotrexate—esophageal cancer	6.06e-05	0.00167	CcSEcCtD
Omeprazole—Neutropenia—Methotrexate—esophageal cancer	6.06e-05	0.00167	CcSEcCtD
Omeprazole—Paraesthesia—Cisplatin—esophageal cancer	6.03e-05	0.00166	CcSEcCtD
Omeprazole—Upper respiratory tract infection—Methotrexate—esophageal cancer	6.02e-05	0.00166	CcSEcCtD
Omeprazole—Dyspnoea—Cisplatin—esophageal cancer	5.98e-05	0.00165	CcSEcCtD
Omeprazole—Flatulence—Capecitabine—esophageal cancer	5.97e-05	0.00165	CcSEcCtD
Omeprazole—Erectile dysfunction—Methotrexate—esophageal cancer	5.96e-05	0.00164	CcSEcCtD
Omeprazole—Dysgeusia—Capecitabine—esophageal cancer	5.94e-05	0.00164	CcSEcCtD
Omeprazole—Photosensitivity reaction—Methotrexate—esophageal cancer	5.91e-05	0.00163	CcSEcCtD
Omeprazole—Back pain—Capecitabine—esophageal cancer	5.86e-05	0.00162	CcSEcCtD
Omeprazole—Decreased appetite—Cisplatin—esophageal cancer	5.83e-05	0.00161	CcSEcCtD
Omeprazole—Muscle spasms—Capecitabine—esophageal cancer	5.83e-05	0.00161	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Cisplatin—esophageal cancer	5.79e-05	0.0016	CcSEcCtD
Omeprazole—Infestation NOS—Methotrexate—esophageal cancer	5.77e-05	0.00159	CcSEcCtD
Omeprazole—Infestation—Methotrexate—esophageal cancer	5.77e-05	0.00159	CcSEcCtD
Omeprazole—Depression—Methotrexate—esophageal cancer	5.76e-05	0.00159	CcSEcCtD
Omeprazole—Pain—Cisplatin—esophageal cancer	5.74e-05	0.00158	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	5.72e-05	0.00158	CcSEcCtD
Omeprazole—Vision blurred—Capecitabine—esophageal cancer	5.71e-05	0.00157	CcSEcCtD
Omeprazole—Lansoprazole—ABCB1—esophageal cancer	5.69e-05	0.0207	CrCbGaD
Omeprazole—Tremor—Capecitabine—esophageal cancer	5.68e-05	0.00156	CcSEcCtD
Omeprazole—Renal failure—Methotrexate—esophageal cancer	5.68e-05	0.00156	CcSEcCtD
Omeprazole—Stomatitis—Methotrexate—esophageal cancer	5.63e-05	0.00155	CcSEcCtD
Omeprazole—Ill-defined disorder—Capecitabine—esophageal cancer	5.62e-05	0.00155	CcSEcCtD
Omeprazole—Conjunctivitis—Methotrexate—esophageal cancer	5.61e-05	0.00155	CcSEcCtD
Omeprazole—Anaemia—Capecitabine—esophageal cancer	5.6e-05	0.00154	CcSEcCtD
Omeprazole—Feeling abnormal—Cisplatin—esophageal cancer	5.53e-05	0.00152	CcSEcCtD
Omeprazole—Haematuria—Methotrexate—esophageal cancer	5.51e-05	0.00152	CcSEcCtD
Omeprazole—Malaise—Capecitabine—esophageal cancer	5.47e-05	0.00151	CcSEcCtD
Omeprazole—Hepatobiliary disease—Methotrexate—esophageal cancer	5.46e-05	0.0015	CcSEcCtD
Omeprazole—Epistaxis—Methotrexate—esophageal cancer	5.45e-05	0.0015	CcSEcCtD
Omeprazole—Vertigo—Capecitabine—esophageal cancer	5.45e-05	0.0015	CcSEcCtD
Omeprazole—Leukopenia—Capecitabine—esophageal cancer	5.43e-05	0.00149	CcSEcCtD
Omeprazole—Agranulocytosis—Methotrexate—esophageal cancer	5.39e-05	0.00148	CcSEcCtD
Omeprazole—Palpitations—Capecitabine—esophageal cancer	5.36e-05	0.00148	CcSEcCtD
Omeprazole—Body temperature increased—Cisplatin—esophageal cancer	5.31e-05	0.00146	CcSEcCtD
Omeprazole—Cough—Capecitabine—esophageal cancer	5.29e-05	0.00146	CcSEcCtD
Omeprazole—Hypertension—Capecitabine—esophageal cancer	5.23e-05	0.00144	CcSEcCtD
Omeprazole—Hepatitis—Methotrexate—esophageal cancer	5.18e-05	0.00143	CcSEcCtD
Omeprazole—Myalgia—Capecitabine—esophageal cancer	5.16e-05	0.00142	CcSEcCtD
Omeprazole—Chest pain—Capecitabine—esophageal cancer	5.16e-05	0.00142	CcSEcCtD
Omeprazole—Arthralgia—Capecitabine—esophageal cancer	5.16e-05	0.00142	CcSEcCtD
Omeprazole—Pharyngitis—Methotrexate—esophageal cancer	5.14e-05	0.00142	CcSEcCtD
Omeprazole—Anxiety—Capecitabine—esophageal cancer	5.14e-05	0.00142	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	5.13e-05	0.00141	CcSEcCtD
Omeprazole—Urinary tract disorder—Methotrexate—esophageal cancer	5.12e-05	0.00141	CcSEcCtD
Omeprazole—Discomfort—Capecitabine—esophageal cancer	5.1e-05	0.0014	CcSEcCtD
Omeprazole—Urethral disorder—Methotrexate—esophageal cancer	5.08e-05	0.0014	CcSEcCtD
Omeprazole—Dry mouth—Capecitabine—esophageal cancer	5.05e-05	0.00139	CcSEcCtD
Omeprazole—Visual impairment—Methotrexate—esophageal cancer	5e-05	0.00138	CcSEcCtD
Omeprazole—Confusional state—Capecitabine—esophageal cancer	4.99e-05	0.00137	CcSEcCtD
Omeprazole—Hypersensitivity—Cisplatin—esophageal cancer	4.94e-05	0.00136	CcSEcCtD
Omeprazole—Infection—Capecitabine—esophageal cancer	4.91e-05	0.00135	CcSEcCtD
Omeprazole—Erythema multiforme—Methotrexate—esophageal cancer	4.9e-05	0.00135	CcSEcCtD
Omeprazole—Shock—Capecitabine—esophageal cancer	4.87e-05	0.00134	CcSEcCtD
Omeprazole—Nervous system disorder—Capecitabine—esophageal cancer	4.85e-05	0.00134	CcSEcCtD
Omeprazole—Eye disorder—Methotrexate—esophageal cancer	4.84e-05	0.00133	CcSEcCtD
Omeprazole—Thrombocytopenia—Capecitabine—esophageal cancer	4.84e-05	0.00133	CcSEcCtD
Omeprazole—ABCB1—lymph node—esophageal cancer	4.84e-05	0.00211	CbGeAlD
Omeprazole—Tinnitus—Methotrexate—esophageal cancer	4.83e-05	0.00133	CcSEcCtD
Omeprazole—Tachycardia—Capecitabine—esophageal cancer	4.83e-05	0.00133	CcSEcCtD
Omeprazole—Asthenia—Cisplatin—esophageal cancer	4.82e-05	0.00133	CcSEcCtD
Omeprazole—Skin disorder—Capecitabine—esophageal cancer	4.81e-05	0.00132	CcSEcCtD
Omeprazole—Hyperhidrosis—Capecitabine—esophageal cancer	4.78e-05	0.00132	CcSEcCtD
Omeprazole—Anorexia—Capecitabine—esophageal cancer	4.72e-05	0.0013	CcSEcCtD
Omeprazole—Immune system disorder—Methotrexate—esophageal cancer	4.68e-05	0.00129	CcSEcCtD
Omeprazole—Mediastinal disorder—Methotrexate—esophageal cancer	4.67e-05	0.00129	CcSEcCtD
Omeprazole—Chills—Methotrexate—esophageal cancer	4.65e-05	0.00128	CcSEcCtD
Omeprazole—Diarrhoea—Cisplatin—esophageal cancer	4.59e-05	0.00126	CcSEcCtD
Omeprazole—Alopecia—Methotrexate—esophageal cancer	4.58e-05	0.00126	CcSEcCtD
Omeprazole—Mental disorder—Methotrexate—esophageal cancer	4.54e-05	0.00125	CcSEcCtD
Omeprazole—Malnutrition—Methotrexate—esophageal cancer	4.51e-05	0.00124	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Capecitabine—esophageal cancer	4.51e-05	0.00124	CcSEcCtD
Omeprazole—Insomnia—Capecitabine—esophageal cancer	4.47e-05	0.00123	CcSEcCtD
Omeprazole—Paraesthesia—Capecitabine—esophageal cancer	4.44e-05	0.00122	CcSEcCtD
Omeprazole—Dysgeusia—Methotrexate—esophageal cancer	4.42e-05	0.00122	CcSEcCtD
Omeprazole—Dyspnoea—Capecitabine—esophageal cancer	4.41e-05	0.00121	CcSEcCtD
Omeprazole—Back pain—Methotrexate—esophageal cancer	4.36e-05	0.0012	CcSEcCtD
Omeprazole—Dyspepsia—Capecitabine—esophageal cancer	4.35e-05	0.0012	CcSEcCtD
Omeprazole—Decreased appetite—Capecitabine—esophageal cancer	4.3e-05	0.00118	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Capecitabine—esophageal cancer	4.27e-05	0.00118	CcSEcCtD
Omeprazole—Vomiting—Cisplatin—esophageal cancer	4.27e-05	0.00118	CcSEcCtD
Omeprazole—Fatigue—Capecitabine—esophageal cancer	4.27e-05	0.00117	CcSEcCtD
Omeprazole—Vision blurred—Methotrexate—esophageal cancer	4.25e-05	0.00117	CcSEcCtD
Omeprazole—Rash—Cisplatin—esophageal cancer	4.23e-05	0.00117	CcSEcCtD
Omeprazole—Pain—Capecitabine—esophageal cancer	4.23e-05	0.00117	CcSEcCtD
Omeprazole—Constipation—Capecitabine—esophageal cancer	4.23e-05	0.00117	CcSEcCtD
Omeprazole—Dermatitis—Cisplatin—esophageal cancer	4.23e-05	0.00116	CcSEcCtD
Omeprazole—Ill-defined disorder—Methotrexate—esophageal cancer	4.19e-05	0.00115	CcSEcCtD
Omeprazole—Anaemia—Methotrexate—esophageal cancer	4.17e-05	0.00115	CcSEcCtD
Omeprazole—Feeling abnormal—Capecitabine—esophageal cancer	4.08e-05	0.00112	CcSEcCtD
Omeprazole—Malaise—Methotrexate—esophageal cancer	4.07e-05	0.00112	CcSEcCtD
Omeprazole—Vertigo—Methotrexate—esophageal cancer	4.05e-05	0.00112	CcSEcCtD
Omeprazole—Gastrointestinal pain—Capecitabine—esophageal cancer	4.05e-05	0.00111	CcSEcCtD
Omeprazole—Leukopenia—Methotrexate—esophageal cancer	4.04e-05	0.00111	CcSEcCtD
Omeprazole—Nausea—Cisplatin—esophageal cancer	3.99e-05	0.0011	CcSEcCtD
Omeprazole—Cough—Methotrexate—esophageal cancer	3.94e-05	0.00108	CcSEcCtD
Omeprazole—Urticaria—Capecitabine—esophageal cancer	3.93e-05	0.00108	CcSEcCtD
Omeprazole—Abdominal pain—Capecitabine—esophageal cancer	3.91e-05	0.00108	CcSEcCtD
Omeprazole—Body temperature increased—Capecitabine—esophageal cancer	3.91e-05	0.00108	CcSEcCtD
Omeprazole—Arthralgia—Methotrexate—esophageal cancer	3.84e-05	0.00106	CcSEcCtD
Omeprazole—Myalgia—Methotrexate—esophageal cancer	3.84e-05	0.00106	CcSEcCtD
Omeprazole—Chest pain—Methotrexate—esophageal cancer	3.84e-05	0.00106	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	3.82e-05	0.00105	CcSEcCtD
Omeprazole—Discomfort—Methotrexate—esophageal cancer	3.8e-05	0.00105	CcSEcCtD
Omeprazole—Confusional state—Methotrexate—esophageal cancer	3.71e-05	0.00102	CcSEcCtD
Omeprazole—Anaphylactic shock—Methotrexate—esophageal cancer	3.68e-05	0.00101	CcSEcCtD
Omeprazole—Infection—Methotrexate—esophageal cancer	3.66e-05	0.00101	CcSEcCtD
Omeprazole—Hypersensitivity—Capecitabine—esophageal cancer	3.64e-05	0.001	CcSEcCtD
Omeprazole—Nervous system disorder—Methotrexate—esophageal cancer	3.61e-05	0.000995	CcSEcCtD
Omeprazole—Thrombocytopenia—Methotrexate—esophageal cancer	3.61e-05	0.000993	CcSEcCtD
Omeprazole—Skin disorder—Methotrexate—esophageal cancer	3.58e-05	0.000985	CcSEcCtD
Omeprazole—Hyperhidrosis—Methotrexate—esophageal cancer	3.56e-05	0.000981	CcSEcCtD
Omeprazole—Asthenia—Capecitabine—esophageal cancer	3.55e-05	0.000978	CcSEcCtD
Omeprazole—Anorexia—Methotrexate—esophageal cancer	3.51e-05	0.000967	CcSEcCtD
Omeprazole—Pruritus—Capecitabine—esophageal cancer	3.5e-05	0.000964	CcSEcCtD
Omeprazole—Diarrhoea—Capecitabine—esophageal cancer	3.38e-05	0.000932	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Methotrexate—esophageal cancer	3.36e-05	0.000924	CcSEcCtD
Omeprazole—Insomnia—Methotrexate—esophageal cancer	3.33e-05	0.000917	CcSEcCtD
Omeprazole—Paraesthesia—Methotrexate—esophageal cancer	3.31e-05	0.000911	CcSEcCtD
Omeprazole—Dyspnoea—Methotrexate—esophageal cancer	3.28e-05	0.000904	CcSEcCtD
Omeprazole—Somnolence—Methotrexate—esophageal cancer	3.27e-05	0.000902	CcSEcCtD
Omeprazole—Dizziness—Capecitabine—esophageal cancer	3.27e-05	0.000901	CcSEcCtD
Omeprazole—Dyspepsia—Methotrexate—esophageal cancer	3.24e-05	0.000893	CcSEcCtD
Omeprazole—Decreased appetite—Methotrexate—esophageal cancer	3.2e-05	0.000882	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Methotrexate—esophageal cancer	3.18e-05	0.000876	CcSEcCtD
Omeprazole—Fatigue—Methotrexate—esophageal cancer	3.18e-05	0.000875	CcSEcCtD
Omeprazole—Pain—Methotrexate—esophageal cancer	3.15e-05	0.000867	CcSEcCtD
Omeprazole—Vomiting—Capecitabine—esophageal cancer	3.15e-05	0.000866	CcSEcCtD
Omeprazole—Rash—Capecitabine—esophageal cancer	3.12e-05	0.000859	CcSEcCtD
Omeprazole—Dermatitis—Capecitabine—esophageal cancer	3.12e-05	0.000858	CcSEcCtD
Omeprazole—Headache—Capecitabine—esophageal cancer	3.1e-05	0.000854	CcSEcCtD
Omeprazole—Feeling abnormal—Methotrexate—esophageal cancer	3.03e-05	0.000836	CcSEcCtD
Omeprazole—Gastrointestinal pain—Methotrexate—esophageal cancer	3.01e-05	0.000829	CcSEcCtD
Omeprazole—Nausea—Capecitabine—esophageal cancer	2.94e-05	0.000809	CcSEcCtD
Omeprazole—Urticaria—Methotrexate—esophageal cancer	2.93e-05	0.000806	CcSEcCtD
Omeprazole—Abdominal pain—Methotrexate—esophageal cancer	2.91e-05	0.000802	CcSEcCtD
Omeprazole—Body temperature increased—Methotrexate—esophageal cancer	2.91e-05	0.000802	CcSEcCtD
Omeprazole—Hypersensitivity—Methotrexate—esophageal cancer	2.71e-05	0.000747	CcSEcCtD
Omeprazole—Asthenia—Methotrexate—esophageal cancer	2.64e-05	0.000728	CcSEcCtD
Omeprazole—Pruritus—Methotrexate—esophageal cancer	2.61e-05	0.000718	CcSEcCtD
Omeprazole—Diarrhoea—Methotrexate—esophageal cancer	2.52e-05	0.000694	CcSEcCtD
Omeprazole—Dizziness—Methotrexate—esophageal cancer	2.44e-05	0.000671	CcSEcCtD
Omeprazole—Vomiting—Methotrexate—esophageal cancer	2.34e-05	0.000645	CcSEcCtD
Omeprazole—Rash—Methotrexate—esophageal cancer	2.32e-05	0.00064	CcSEcCtD
Omeprazole—Dermatitis—Methotrexate—esophageal cancer	2.32e-05	0.000639	CcSEcCtD
Omeprazole—Headache—Methotrexate—esophageal cancer	2.31e-05	0.000635	CcSEcCtD
Omeprazole—Nausea—Methotrexate—esophageal cancer	2.19e-05	0.000603	CcSEcCtD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	3.87e-06	8.63e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—CREBBP—esophageal cancer	3.87e-06	8.62e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ADH1B—esophageal cancer	3.86e-06	8.6e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—HMOX1—esophageal cancer	3.85e-06	8.57e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP26A1—esophageal cancer	3.84e-06	8.56e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CYP19A1—esophageal cancer	3.83e-06	8.55e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ALOX15—esophageal cancer	3.83e-06	8.54e-05	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	3.79e-06	8.44e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GAPDH—esophageal cancer	3.78e-06	8.43e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.77e-06	8.41e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ADH7—esophageal cancer	3.76e-06	8.38e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PLCE1—esophageal cancer	3.76e-06	8.38e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CRABP1—esophageal cancer	3.75e-06	8.35e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ALOX15—esophageal cancer	3.74e-06	8.34e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—TYMP—esophageal cancer	3.72e-06	8.29e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.72e-06	8.28e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—ABCB1—esophageal cancer	3.69e-06	8.23e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—TYMP—esophageal cancer	3.69e-06	8.22e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.68e-06	8.21e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—TPI1—esophageal cancer	3.66e-06	8.15e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTO1—esophageal cancer	3.66e-06	8.15e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ALDH2—esophageal cancer	3.64e-06	8.12e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP26A1—esophageal cancer	3.62e-06	8.06e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP26A1—esophageal cancer	3.59e-06	7.99e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTO1—esophageal cancer	3.57e-06	7.96e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—TPI1—esophageal cancer	3.57e-06	7.96e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GNG7—esophageal cancer	3.56e-06	7.94e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ALOX15—esophageal cancer	3.53e-06	7.86e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ALDOB—esophageal cancer	3.51e-06	7.81e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—HMOX1—esophageal cancer	3.5e-06	7.8e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ALOX15—esophageal cancer	3.49e-06	7.79e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GSTT1—esophageal cancer	3.46e-06	7.72e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—NOS3—esophageal cancer	3.46e-06	7.72e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CYP2A6—esophageal cancer	3.42e-06	7.63e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ALDOB—esophageal cancer	3.42e-06	7.63e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CA1—esophageal cancer	3.41e-06	7.61e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SLC10A2—esophageal cancer	3.41e-06	7.61e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.41e-06	7.6e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GAPDH—esophageal cancer	3.37e-06	7.52e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—TPI1—esophageal cancer	3.36e-06	7.5e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTO1—esophageal cancer	3.36e-06	7.5e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—ABCB1—esophageal cancer	3.36e-06	7.49e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—CREBBP—esophageal cancer	3.35e-06	7.46e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CRABP1—esophageal cancer	3.34e-06	7.45e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ALDH2—esophageal cancer	3.34e-06	7.44e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—TPI1—esophageal cancer	3.33e-06	7.43e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTO1—esophageal cancer	3.33e-06	7.43e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ADH1B—esophageal cancer	3.3e-06	7.35e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GAPDH—esophageal cancer	3.29e-06	7.34e-05	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	3.29e-06	7.33e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CRABP1—esophageal cancer	3.26e-06	7.28e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—CREBBP—esophageal cancer	3.26e-06	7.26e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ENO1—esophageal cancer	3.25e-06	7.24e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTGS1—esophageal cancer	3.25e-06	7.24e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ALDOB—esophageal cancer	3.22e-06	7.19e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PSME2—esophageal cancer	3.2e-06	7.13e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PSME1—esophageal cancer	3.2e-06	7.13e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ALDOB—esophageal cancer	3.2e-06	7.13e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GNG7—esophageal cancer	3.18e-06	7.09e-05	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	3.18e-06	7.09e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GSTT1—esophageal cancer	3.18e-06	7.08e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PTGS2—esophageal cancer	3.17e-06	7.06e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—TYMP—esophageal cancer	3.15e-06	7.02e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP2A6—esophageal cancer	3.14e-06	7e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.13e-06	6.97e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CA2—esophageal cancer	3.12e-06	6.96e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GNG7—esophageal cancer	3.1e-06	6.92e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GAPDH—esophageal cancer	3.1e-06	6.92e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GAPDH—esophageal cancer	3.08e-06	6.86e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CRABP1—esophageal cancer	3.08e-06	6.86e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP26A1—esophageal cancer	3.06e-06	6.83e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CRABP1—esophageal cancer	3.05e-06	6.8e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—NOS3—esophageal cancer	3e-06	6.68e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ALOX15—esophageal cancer	2.99e-06	6.66e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ALDH2—esophageal cancer	2.98e-06	6.64e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ENO1—esophageal cancer	2.98e-06	6.64e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTGS1—esophageal cancer	2.98e-06	6.64e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PSME1—esophageal cancer	2.93e-06	6.54e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PSME2—esophageal cancer	2.93e-06	6.54e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GNG7—esophageal cancer	2.93e-06	6.52e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—NOS3—esophageal cancer	2.91e-06	6.5e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ALDH2—esophageal cancer	2.91e-06	6.49e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.9e-06	6.47e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ADH7—esophageal cancer	2.9e-06	6.47e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GNG7—esophageal cancer	2.9e-06	6.47e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—TPI1—esophageal cancer	2.85e-06	6.35e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTO1—esophageal cancer	2.85e-06	6.35e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTT1—esophageal cancer	2.84e-06	6.32e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP2A6—esophageal cancer	2.8e-06	6.25e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.79e-06	6.23e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.79e-06	6.22e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.79e-06	6.22e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTT1—esophageal cancer	2.77e-06	6.17e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CYP1B1—esophageal cancer	2.76e-06	6.15e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ALDH2—esophageal cancer	2.74e-06	6.11e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PTGS2—esophageal cancer	2.74e-06	6.11e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP2A6—esophageal cancer	2.74e-06	6.1e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ALDOB—esophageal cancer	2.73e-06	6.09e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ALDH2—esophageal cancer	2.72e-06	6.06e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTGS2—esophageal cancer	2.67e-06	5.94e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTGS1—esophageal cancer	2.66e-06	5.92e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ENO1—esophageal cancer	2.66e-06	5.92e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—EP300—esophageal cancer	2.63e-06	5.87e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GAPDH—esophageal cancer	2.63e-06	5.86e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PSME2—esophageal cancer	2.62e-06	5.84e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PSME1—esophageal cancer	2.62e-06	5.84e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTT1—esophageal cancer	2.61e-06	5.81e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CRABP1—esophageal cancer	2.61e-06	5.81e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CYP19A1—esophageal cancer	2.6e-06	5.79e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTGS1—esophageal cancer	2.59e-06	5.78e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ENO1—esophageal cancer	2.59e-06	5.78e-05	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.59e-06	5.78e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTT1—esophageal cancer	2.59e-06	5.76e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP2A6—esophageal cancer	2.58e-06	5.75e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.56e-06	5.71e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP2A6—esophageal cancer	2.56e-06	5.7e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PSME1—esophageal cancer	2.56e-06	5.7e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PSME2—esophageal cancer	2.56e-06	5.7e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.55e-06	5.67e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ADH1B—esophageal cancer	2.54e-06	5.67e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP1B1—esophageal cancer	2.53e-06	5.64e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GNG7—esophageal cancer	2.48e-06	5.53e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CREBBP—esophageal cancer	2.47e-06	5.5e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ENO1—esophageal cancer	2.44e-06	5.45e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTGS1—esophageal cancer	2.44e-06	5.45e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—TYMP—esophageal cancer	2.43e-06	5.42e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ENO1—esophageal cancer	2.42e-06	5.4e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTGS1—esophageal cancer	2.42e-06	5.4e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PSME2—esophageal cancer	2.41e-06	5.37e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PSME1—esophageal cancer	2.41e-06	5.37e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PSME1—esophageal cancer	2.39e-06	5.32e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PSME2—esophageal cancer	2.39e-06	5.32e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP19A1—esophageal cancer	2.38e-06	5.3e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—HMOX1—esophageal cancer	2.37e-06	5.28e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.37e-06	5.27e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.32e-06	5.18e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ALDH2—esophageal cancer	2.32e-06	5.18e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.3e-06	5.14e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.29e-06	5.1e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—EP300—esophageal cancer	2.28e-06	5.08e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ABCB1—esophageal cancer	2.27e-06	5.07e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP1B1—esophageal cancer	2.26e-06	5.04e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CREBBP—esophageal cancer	2.24e-06	5e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—EP300—esophageal cancer	2.22e-06	4.94e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTT1—esophageal cancer	2.21e-06	4.92e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—NOS3—esophageal cancer	2.21e-06	4.92e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP1B1—esophageal cancer	2.2e-06	4.91e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.2e-06	4.9e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—TPI1—esophageal cancer	2.2e-06	4.9e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP2A6—esophageal cancer	2.18e-06	4.87e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.18e-06	4.85e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—HMOX1—esophageal cancer	2.17e-06	4.84e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.13e-06	4.75e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP19A1—esophageal cancer	2.12e-06	4.73e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALDOB—esophageal cancer	2.11e-06	4.7e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.08e-06	4.65e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ABCB1—esophageal cancer	2.08e-06	4.65e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP1B1—esophageal cancer	2.08e-06	4.63e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP19A1—esophageal cancer	2.07e-06	4.62e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTGS1—esophageal cancer	2.07e-06	4.61e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ENO1—esophageal cancer	2.07e-06	4.61e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP1B1—esophageal cancer	2.06e-06	4.59e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PSME1—esophageal cancer	2.04e-06	4.55e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PSME2—esophageal cancer	2.04e-06	4.55e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GAPDH—esophageal cancer	2.03e-06	4.52e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTGS2—esophageal cancer	2.02e-06	4.5e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CRABP1—esophageal cancer	2.01e-06	4.48e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—NOS3—esophageal cancer	2.01e-06	4.48e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP19A1—esophageal cancer	1.95e-06	4.35e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CA—esophageal cancer	1.95e-06	4.34e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—HMOX1—esophageal cancer	1.94e-06	4.32e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.94e-06	4.32e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GNG7—esophageal cancer	1.91e-06	4.26e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.9e-06	4.24e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—HMOX1—esophageal cancer	1.89e-06	4.22e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ABCB1—esophageal cancer	1.86e-06	4.15e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTGS2—esophageal cancer	1.84e-06	4.1e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.79e-06	4e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—HMOX1—esophageal cancer	1.78e-06	3.97e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.78e-06	3.97e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—HMOX1—esophageal cancer	1.77e-06	3.94e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP1B1—esophageal cancer	1.76e-06	3.92e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.73e-06	3.86e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.72e-06	3.83e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.71e-06	3.81e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.7e-06	3.8e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ABCB1—esophageal cancer	1.7e-06	3.78e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CA—esophageal cancer	1.69e-06	3.76e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.69e-06	3.76e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—EP300—esophageal cancer	1.68e-06	3.75e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP19A1—esophageal cancer	1.65e-06	3.69e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CA—esophageal cancer	1.64e-06	3.66e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ENO1—esophageal cancer	1.6e-06	3.56e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.6e-06	3.56e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.58e-06	3.51e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PSME2—esophageal cancer	1.57e-06	3.51e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PSME1—esophageal cancer	1.57e-06	3.51e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—EP300—esophageal cancer	1.53e-06	3.41e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CREBBP—esophageal cancer	1.52e-06	3.39e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—HMOX1—esophageal cancer	1.51e-06	3.37e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.48e-06	3.3e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ABCB1—esophageal cancer	1.45e-06	3.23e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.41e-06	3.14e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CREBBP—esophageal cancer	1.39e-06	3.1e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—NOS3—esophageal cancer	1.36e-06	3.03e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.36e-06	3.03e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.28e-06	2.86e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.28e-06	2.85e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—NOS3—esophageal cancer	1.25e-06	2.78e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTGS2—esophageal cancer	1.24e-06	2.77e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CREBBP—esophageal cancer	1.24e-06	2.77e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CA—esophageal cancer	1.24e-06	2.77e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CREBBP—esophageal cancer	1.21e-06	2.71e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.17e-06	2.6e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CREBBP—esophageal cancer	1.14e-06	2.55e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTGS2—esophageal cancer	1.14e-06	2.54e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CREBBP—esophageal cancer	1.13e-06	2.53e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CA—esophageal cancer	1.13e-06	2.52e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.12e-06	2.49e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—NOS3—esophageal cancer	1.11e-06	2.48e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.1e-06	2.44e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—NOS3—esophageal cancer	1.09e-06	2.42e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—EP300—esophageal cancer	1.03e-06	2.31e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—NOS3—esophageal cancer	1.02e-06	2.28e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTGS2—esophageal cancer	1.02e-06	2.27e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—NOS3—esophageal cancer	1.01e-06	2.26e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTGS2—esophageal cancer	9.94e-07	2.22e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CREBBP—esophageal cancer	9.69e-07	2.16e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—EP300—esophageal cancer	9.49e-07	2.11e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTGS2—esophageal cancer	9.36e-07	2.09e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTGS2—esophageal cancer	9.28e-07	2.07e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NOS3—esophageal cancer	8.67e-07	1.93e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—EP300—esophageal cancer	8.47e-07	1.89e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—EP300—esophageal cancer	8.26e-07	1.84e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTGS2—esophageal cancer	7.93e-07	1.77e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—EP300—esophageal cancer	7.79e-07	1.74e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—EP300—esophageal cancer	7.72e-07	1.72e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CA—esophageal cancer	7.65e-07	1.71e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CREBBP—esophageal cancer	7.48e-07	1.67e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CA—esophageal cancer	7.02e-07	1.56e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NOS3—esophageal cancer	6.69e-07	1.49e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—EP300—esophageal cancer	6.6e-07	1.47e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CA—esophageal cancer	6.26e-07	1.4e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTGS2—esophageal cancer	6.12e-07	1.36e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CA—esophageal cancer	6.11e-07	1.36e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CA—esophageal cancer	5.76e-07	1.28e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CA—esophageal cancer	5.71e-07	1.27e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—EP300—esophageal cancer	5.09e-07	1.14e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CA—esophageal cancer	4.88e-07	1.09e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CA—esophageal cancer	3.77e-07	8.4e-06	CbGpPWpGaD
